New NIH research revealed why GLP-1 receptor agonists eventually stop working by showing that appetite-regulating neurons respond differently over time.
Tag: weight loss
GLP-1 Drugs at Lower Doses Shown to Maintain Weight Loss Outcomes in New Trials
Two clinical trials found that reduced doses of GLP-1 weight-loss medications and newer oral pills like Foundayo can maintain weight loss outcomes lowering costs and side effects.
Lower-Dose GLP-1 Drugs or Oral Pill Foundayo Can Maintain Weight Loss Per Clinical Trials
Two clinical trials suggest patients can switch to lighter formulations without regaining the weight they lost.
The GLP-1 Drug Debate: Are We Overprescribing Weight-Loss Injections?
A personal account and opinion piece on how semaglutide is reshaping diet culture.
The Obesity-Immune System Link: What the New Research Means for You
New science shows obesity leaves a lasting mark on the immune system even after weight loss — here’s what that means practically.